Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

European Commission grants marketing authorization for Atripla for HIV-1

Dec. 19, 2007

HIV replication inhibitors prepared and tested at Boehringer Ingelheim

Dec. 17, 2007

Panacos reports positive results from 350 mg cohort of phase IIb study of bevirimat

Dec. 14, 2007

Bristol-Myers and Gilead enter agreement to commercialize Atripla in Europe

Dec. 14, 2007

Sequoia Pharmaceuticals submits IND application for SPI-452

Dec. 12, 2007

Myriad Genetics submits IND on Vivecon

Dec. 10, 2007

Abbott makes Aluvia available to Ugandan children with HIV/AIDS

Dec. 5, 2007

Health Canada approves Merck Frosst's Isentress for HIV-1

Dec. 4, 2007

Janssen granted approval for Prezista 300 mg tablet for HIV

Nov. 30, 2007

Ardea reports further positive results from the phase I MAD study of RDEA-806

Nov. 30, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld
Hematopoietic stem cell research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...